Advancing Cancer Diagnostics
Improving Lives
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

From Diagnosis to Treatment - Part 3 of 4, Diagnosis of Breast Cancer with H&E and Immunohistochemistry Stains

PACE credits are no longer available for webinars more than 6 months old.


In the case of Breast Cancer, the patient’s cancer is usually detected by a mammogram or palpitation of an experienced Physician. However, these first indications that something is wrong must be confirmed by a more scientific approach. Usually what follows is an actual biopsy; a sample of the tissue in question is removed from the person. Once a tumor is confirmed from the biopsy, then a more radical surgical approach may be necessary or other treatments are performed. Part 3 of the series addresses the importance of proper H&E/ICH sections and staining for diagnosis of breast tumors.  A view of optimization and controls for prognostic markers will be examined, and brief overview of IHC diagnosis and treatment will presented.


Learning Objectives:

Discuss the importance of good H&E /IHC sections, and differences in the pathologist’s evaluation of core versus whole-section specimens.

  1. Understand the differential diagnosis of types of breast tumors.
  2. To view a good optimization of the antibody as an essential part of laboratory practice.
  3. Examine a variety of controls for prognostic (graded) IHC markers such as ER/PR/HER2.
  4. A brief overview of the next steps after IHC diagnosis and treatment.